| Literature DB >> 24130207 |
M K Parvathidevi1, Shrinivas Koppal, Thriveni Rukmangada, Amit R Byatnal.
Abstract
The use of multiple weekly intralesional injections of 3% sodium tetradecyl sulfate as a sclerosing agent for the management of facial haemangiomas is a safe treatment with acceptable results. As presented in this case report, this technique offers the patient considerable relief of symptoms with minimal complications. However, the possibility of second-stage surgery to correct residual deformity is still considered. Sclerotherapy with 3% sodium tetradecyl sulfate provides a good preparation for further surgery.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24130207 PMCID: PMC3822101 DOI: 10.1136/bcr-2013-200660
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X